22.8 C
New York
Thursday, July 18, 2024

Tag: HyBryteTM

A grant for the development of orphan products in the amount of $2.6 million has been awarded by the Food and Drug Administration of...

Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercialising products to treat rare diseases where there is an unmet medical...

- A word from our sponsors -

Follow us

HomeTagsHyBryteTM